Comeau AM - Search Results

1

Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report.

Comeau AM, Accurso FJ, White TB, Campbell PW 3rd, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP; Cystic Fibrosis Foundation. Comeau AM, et al. Pediatrics. 2007 Feb;119(2):e495-518. doi: 10.1542/peds.2006-1993. Pediatrics. 2007. PMID: 17272609

2

Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center.

Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW. Wheeler PG, et al. Among authors: comeau am. Genet Med. 2001 Nov-Dec;3(6):411-5. doi: 10.1097/00125817-200111000-00006. Genet Med. 2001. PMID: 11715005 Free article.

3

Newborn screening: new developments in a proven field.

Eaton RB, Comeau AM, Zytkovicz TH, Larson C. Eaton RB, et al. Among authors: comeau am. Clin Lab Sci. 2002 Fall;15(4):239-44. Clin Lab Sci. 2002. PMID: 12776784 No abstract available.

4

Newborn screening for cystic fibrosis.

Parad RB, Comeau AM. Parad RB, et al. Among authors: comeau am. Pediatr Ann. 2003 Aug;32(8):528-35. doi: 10.3928/0090-4481-20030801-10. Pediatr Ann. 2003. PMID: 12942895

5

Integration of new genetic diseases into statewide newborn screening: New England experience.

Comeau AM, Larson C, Eaton RB. Comeau AM, et al. Am J Med Genet C Semin Med Genet. 2004 Feb 15;125C(1):35-41. doi: 10.1002/ajmg.c.30001. Am J Med Genet C Semin Med Genet. 2004. PMID: 14755432

6

Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections.

Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Comeau AM, et al. Pediatrics. 2004 Jun;113(6):1573-81. doi: 10.1542/peds.113.6.1573. Pediatrics. 2004. PMID: 15173476

7

Newborn screening for cystic fibrosis: evaluation of benefits and risks and recommendations for state newborn screening programs.

Grosse SD, Boyle CA, Botkin JR, Comeau AM, Kharrazi M, Rosenfeld M, Wilfond BS; CDC. Grosse SD, et al. Among authors: comeau am. MMWR Recomm Rep. 2004 Oct 15;53(RR-13):1-36. MMWR Recomm Rep. 2004. PMID: 15483524 Free article. Review.

8

Sweat testing infants detected by cystic fibrosis newborn screening.

Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP. Parad RB, et al. Among authors: comeau am. J Pediatr. 2005 Sep;147(3 Suppl):S69-72. doi: 10.1016/j.jpeds.2005.08.015. J Pediatr. 2005. PMID: 16202787

9

Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.

Parad RB, Comeau AM. Parad RB, et al. Among authors: comeau am. J Pediatr. 2005 Sep;147(3 Suppl):S78-82. doi: 10.1016/j.jpeds.2005.08.017. J Pediatr. 2005. PMID: 16202789

10

Challenges in implementing a successful newborn cystic fibrosis screening program.

Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Comeau AM, et al. J Pediatr. 2005 Sep;147(3 Suppl):S89-93. doi: 10.1016/j.jpeds.2005.08.006. J Pediatr. 2005. PMID: 16202791 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

131 results

Search Page

Filters